DK370484A - Hidtil ukendte nitroxylforbindelser, fremgangsmaade til deres fremstilling og diagnostiske midler indeholdende dem - Google Patents

Hidtil ukendte nitroxylforbindelser, fremgangsmaade til deres fremstilling og diagnostiske midler indeholdende dem Download PDF

Info

Publication number
DK370484A
DK370484A DK370484A DK370484A DK370484A DK 370484 A DK370484 A DK 370484A DK 370484 A DK370484 A DK 370484A DK 370484 A DK370484 A DK 370484A DK 370484 A DK370484 A DK 370484A
Authority
DK
Denmark
Prior art keywords
procedures
preparation
diagnostic agents
agents containing
nitroxyl compounds
Prior art date
Application number
DK370484A
Other languages
English (en)
Other versions
DK370484D0 (da
DK172065B1 (da
Inventor
Heinz Gries
Ulrich Niedballa
Hanns-Joachim Weinmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK370484D0 publication Critical patent/DK370484D0/da
Publication of DK370484A publication Critical patent/DK370484A/da
Application granted granted Critical
Publication of DK172065B1 publication Critical patent/DK172065B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/20Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94Oxygen atom, e.g. piperidine N-oxide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK370484A 1983-08-03 1984-07-30 Diagnostiske midler indeholdende nitroxylforbindelser, samt hidtil ukendte nitroxylforbindelser og fremgangsmåde til deres fremstilling DK172065B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833328365 DE3328365A1 (de) 1983-08-03 1983-08-03 Neue diagnostische mittel
DE3328365 1983-08-03

Publications (3)

Publication Number Publication Date
DK370484D0 DK370484D0 (da) 1984-07-30
DK370484A true DK370484A (da) 1985-02-04
DK172065B1 DK172065B1 (da) 1997-10-13

Family

ID=6205912

Family Applications (1)

Application Number Title Priority Date Filing Date
DK370484A DK172065B1 (da) 1983-08-03 1984-07-30 Diagnostiske midler indeholdende nitroxylforbindelser, samt hidtil ukendte nitroxylforbindelser og fremgangsmåde til deres fremstilling

Country Status (8)

Country Link
US (2) US4925652A (da)
EP (1) EP0133674B1 (da)
JP (1) JPH0657694B2 (da)
AT (1) ATE46445T1 (da)
CA (1) CA1230114A (da)
DE (2) DE3328365A1 (da)
DK (1) DK172065B1 (da)
IE (1) IE57665B1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3328365A1 (de) * 1983-08-03 1985-02-21 Schering AG, 1000 Berlin und 4709 Bergkamen Neue diagnostische mittel
US4834964A (en) * 1986-03-07 1989-05-30 M.R.I., Inc. Use of charged nitroxides as NMR image enhancing agents for CSF
US4984573A (en) * 1987-06-23 1991-01-15 Hafslund Nycomed Innovation Ab Method of electron spin resonance enhanced magnetic resonance imaging
GB8817137D0 (en) * 1988-07-19 1988-08-24 Nycomed As Compositions
US5730954A (en) * 1988-08-23 1998-03-24 Schering Aktiengesellschaft Preparation comprising cavitate- or clathrate-forming host/guest complexes as contrast agent
US5314681A (en) * 1988-12-23 1994-05-24 Nycomed Innovation Ab Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging
JP3175940B2 (ja) * 1990-02-12 2001-06-11 ニコムド イノベーション アーベー トリアリールメチルラジカルおよび磁気共鳴造影法における不活性炭素フリーラジカルの用途
GB9015684D0 (en) * 1990-07-17 1990-09-05 Medical Res Council Synthesis and uses of spin labelled ribonucleosides and ribonucleotides
US5264204A (en) * 1992-04-30 1993-11-23 Mallinckrodt Medical, Inc. Hydrophilic free radicals for magnetic resonance imaging
US5593688A (en) * 1993-06-25 1997-01-14 Nexstar Pharmaceuticals, Inc. Liposomal targeting of ischemic tissue
US5804561A (en) * 1993-08-16 1998-09-08 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5817632A (en) * 1993-08-16 1998-10-06 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5807831A (en) * 1993-08-16 1998-09-15 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5741893A (en) * 1993-08-16 1998-04-21 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5725839A (en) * 1993-08-16 1998-03-10 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
US5840701A (en) * 1993-08-16 1998-11-24 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5824781A (en) * 1993-08-16 1998-10-20 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5767089A (en) * 1993-08-16 1998-06-16 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
TW381022B (en) * 1993-08-16 2000-02-01 Hsia Jen Chang Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
WO1997024145A1 (fr) * 1995-12-28 1997-07-10 Daiichi Radioisotope Laboratories, Ltd. Medicaments d'aide au diagnostic
AU7934298A (en) * 1997-06-27 1999-01-19 Daiichi Radioisotope Laboratories, Ltd. Novel nitroxyl compounds and drugs and reagents containing the same as the active ingredient
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
FR2788272B1 (fr) * 1999-01-08 2001-03-16 Atochem Elf Sa Procede de preparation de nitroxydes
AU784130B2 (en) * 1999-12-10 2006-02-09 Gerald M. Rosen Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in MRI imaging of joints
WO2006124726A2 (en) * 2005-05-12 2006-11-23 The General Hospital Corporation Novel biotinylated compositions
US10202342B2 (en) * 2008-06-27 2019-02-12 University Of Maryland, Baltimore Targeted delivery of imaging probes for in vivo cellular imaging
JP5581012B2 (ja) * 2009-06-15 2014-08-27 住友精化株式会社 3−ホルミル−2,2,5,5−テトラメチルピロリン−1−オキシルの製造方法
CA2883130A1 (en) 2012-08-31 2014-03-06 The General Hospital Corporation Biotin complexes for treatment and diagnosis of alzheimer's disease
US10144707B2 (en) * 2017-03-07 2018-12-04 Organic Energy Devices (Oed) Tritiated nitroxides and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1501115A (fr) * 1965-10-15 1967-11-10 Synvar Ass Marquage de molécules biologiques par résonance de spin électronique
SE353504B (da) * 1967-05-15 1973-02-05 Gd Soc Accomandita Semplice Di
US3507876A (en) * 1967-06-09 1970-04-21 Synvar Ass Pyrrolidine and piperidine nitroxide spin labelling compounds
US3959287A (en) * 1972-07-10 1976-05-25 Syva Company Ligand determination of spin labeled compounds by receptor displacement
FR2235103A1 (en) * 1973-06-29 1975-01-24 Commissariat Energie Atomique Marked nitroxide derivatives of saccharides - by reaction of acid nitroxide with halogenated saccharides
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
DE3328365A1 (de) * 1983-08-03 1985-02-21 Schering AG, 1000 Berlin und 4709 Bergkamen Neue diagnostische mittel
US4656026A (en) * 1984-12-10 1987-04-07 University Of Iowa Research Foundation Magnetic resonance (MR) image enhancement compounds for specific areas of the brain
US4834964A (en) * 1986-03-07 1989-05-30 M.R.I., Inc. Use of charged nitroxides as NMR image enhancing agents for CSF

Also Published As

Publication number Publication date
ATE46445T1 (de) 1989-10-15
DK370484D0 (da) 1984-07-30
JPH0657694B2 (ja) 1994-08-03
IE841992L (en) 1985-02-03
EP0133674B1 (de) 1989-09-20
DE3479787D1 (en) 1989-10-26
CA1230114A (en) 1987-12-08
DK172065B1 (da) 1997-10-13
JPS6094960A (ja) 1985-05-28
US4925652A (en) 1990-05-15
EP0133674A1 (de) 1985-03-06
IE57665B1 (en) 1993-02-24
DE3328365A1 (de) 1985-02-21
US4845090A (en) 1989-07-04

Similar Documents

Publication Publication Date Title
DK370484D0 (da) Hidtil ukendte nitroxylforbindelser, fremgangsmaade til deres fremstiling og diagnostiske midler indeholdende dem
ZA846093B (en) Heptaose compounds,preparation and use thereof
TNSN88009A1 (fr) Diones cycliques
AU631743B2 (en) New chalcones, process for preparing these and pharmaceutical compositions containing them
DE69117084D1 (de) Chelatbildende Verbindungen und ihre Verwendung
SE8501613D0 (sv) Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
ATE3111T1 (de) Verfahren zur herstellung von phenyl-propylmorpholin- und -piperidin-derivaten.
DE69029861D1 (de) N-acyl-substituierte azazyklische verbindungen, verfahren zu deren herstellung und deren verwendung als arzneimittel
RO87991A (ro) Procedeu pentru prepararea unor esteri tiazolidinici substituiti ai unor acizi minerali
GB2005246A (en) beta -Lactam compounds and processes for their preparation
ATE34740T1 (de) (bis(hydroxymethyl)methyl)-isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
FR2485000B1 (da)
DK256982A (da) Fremgangsmaade til fremstilling af n-phthalidyl-5-flyoruracilderivater
DK0478559T3 (da) Forbedret fremgangsmåde til fremstilling af kentonforbindelser
ES471872A1 (es) Un procedimiento de preparacion de tetrahidro-s-triazin-tio-nas acaricidas
ES8201205A1 (es) Procedimiento para la preparacion de nuevos compuestos de aminoantipirina
AU9075582A (en) New ketals of 3:"-dehydrocardenolide tridigitoxosides
ES8300752A1 (es) "un procedimiento para la preparacion de derivados de n-ftalidil-5-fluorouracilo".
DK1056769T3 (da) 15-methyl-cyclopropanosteroider og fremgangsmåde til deres fremstilling
MY101624A (en) Novel compounds and prosesses.
YU55491A (sh) Novi supstituisani 3-cijano-2-piridoni i postupak za njihovo dobijanje
ES297480A1 (es) Procedimiento para la obtenciën de amida de acidos fenilalcoilcarboxilicos

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed